Influence of Body Weight on Cost-Effectiveness of Bone Densitometry and Treatment for Osteoporosis Among Older Women and Men Without Prior Fracture

被引:0
|
作者
Schousboe, J. T. [1 ]
Taylor, B. C. [2 ]
Fink, H. A. [2 ]
Adler, R. A. [3 ]
Gourlay, M. [4 ]
Orwoll, E. S. [5 ]
Barrett-Connor, E. [6 ]
Cummings, S. R. [7 ]
Melton, L. J. [8 ]
Ensrud, K. E. [2 ]
机构
[1] Univ Minnesota, Div Hlth Policy & Management, Pk Nicollet Clin, Minneapolis, MN USA
[2] Univ Minnesota, Minneapolis VAMC, Minneapolis, MN USA
[3] Richmond VAMC, Richmond, VA USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[6] Univ Calif San Diego, San Diego, CA 92103 USA
[7] San Francisco Coordinating Ctr, San Francisco, CA USA
[8] Mayo Clin, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S124 / S124
页数:1
相关论文
共 50 条
  • [41] Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture
    Jacob, L.
    Dreher, M.
    Kostev, K.
    Hadji, P.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (03) : 963 - 969
  • [42] Cost-Effectiveness of Ibandronate Therapy for Women with Postmenopausal Osteoporosis with Respect to Nonvertebral Fracture Efficacy.
    Sunyecz, J. A.
    Silberman, C.
    Poston, S.
    Earnshaw, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S213 - S213
  • [43] The Cost-Effectiveness of an RCT to Establish Whether 5 or 10 Years of Bisphosphonate Treatment Is the Better Duration for Women With a Prior Fracture
    Stevenson, Matt D.
    Oakley, Jeremy E.
    Jones, Myfawny Lloyd
    Brennan, Alan
    Compston, Juliet E.
    McCloskey, Eugene V.
    Selby, Peter L.
    MEDICAL DECISION MAKING, 2009, 29 (06) : 678 - 689
  • [44] Risedronate versus alendronate in older patients with osteoporosis at high risk of fracture: an Italian cost-effectiveness analysis
    Berto, Patrizia
    Maggi, Stefania
    Noale, Marianna
    Lopatriello, Stefania
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 22 (02) : 179 - 188
  • [45] Risedronate versus alendronate in older patients with osteoporosis at high risk of fracture: an Italian cost-effectiveness analysis
    Patrizia Berto
    Stefania Maggi
    Marianna Noale
    Stefania Lopatriello
    Aging Clinical and Experimental Research, 2010, 22 : 179 - 188
  • [46] Cost-Effectiveness of Using Clinical Risk Factors with and without DXA for Osteoporosis Screening in Postmenopausal Women
    Mueller, Dirk
    Gandjour, Afschin
    VALUE IN HEALTH, 2009, 12 (08) : 1106 - 1117
  • [47] Comparing the cost-effectiveness of the Otago Exercise Programme among older women and men: A secondary analysis of a randomized controlled trial
    Davis, Jennifer C.
    Hsu, Chun Liang
    Barha, Cindy
    Jehu, Deborah A.
    Chan, Patrick
    Ghag, Cheyenne
    Jacova, Patrizio
    Adjetey, Cassandra
    Dian, Larry
    Parmar, Naaz
    Madden, Kenneth
    Liu-Ambrose, Teresa
    PLOS ONE, 2022, 17 (04):
  • [48] COMPARING THE COST-EFFECTIVENESS OF THE OTAGO EXERCISE PROGRAMME AMONG OLDER WOMEN AND MEN: A SECONDARY ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL
    Davis, J.
    Hsu, C. L.
    Barha, C.
    Jehu, D. A.
    Chan, P.
    Ghag, C.
    Jacova, P.
    Adjetey, C.
    Dian, L.
    Parmar, N.
    Madden, K.
    Liu-Ambrose, T.
    VALUE IN HEALTH, 2022, 25 (07) : S341 - S341
  • [49] COST-EFFECTIVENESS OF DENOSUMAB FOR THE TREATMENT OF ELDERLY WOMEN WITH POST-MENOPAUSAL OSTEOPOROSIS IN SWEDEN
    Lundkvist, J.
    Loethgren, M.
    Badamgarav, E.
    Freyschyss, B.
    VALUE IN HEALTH, 2012, 15 (07) : A445 - A446
  • [50] Cost-effectiveness of sequential daily teriparatide/weekly alendronate compared with alendronate monotherapy for older osteoporotic women with prior vertebral fracture in Japan
    Mori, Takahiro
    Crandall, Carolyn J.
    Fuji, Tomoko
    Ganz, David A.
    ARCHIVES OF OSTEOPOROSIS, 2021, 16 (01)